by Walter Gunzburg | Apr 23, 2026 | News
“SG Austria/Austrianova appoints biotech investor C. Thomas Paschall to its Board following a successful 2025 funding round, strengthening global growth, partnerships, and strategic expansion initiatives.” SINGAPORE – April 21, 2026 – SG...
by Walter Gunzburg | Nov 19, 2025 | News, Press Release
LAS VEGAS, NEVADA, November 18, 2025 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology company focused on developing cell-based therapies for diabetes and age-related disorders, today announced that its 50/50 joint venture...
by Walter Gunzburg | Sep 19, 2025 | News, Press Release
LAS VEGAS, Sept. 18, 2025 /PRNewswire/ — Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), a Nevada-based corporation, and Austrianova (SGAustria Pte. Ltd.), a Singapore-based biotechnology leader, today announced the...
by Walter Gunzburg | Aug 17, 2024 | Scientific Publications
Austrianova Singapore Pte Ltd., 2 International Business Park, The Strategy @ IBP #09-04, Singapore 609930, Singapore; salmons@sgaustria.com Institute of Virology, Department of Pathobiology, University of Veterinary Medicine, 1210 Vienna, Austria* Correspondence:...
by Walter Gunzburg | Jan 8, 2024 | Press Release
Austrianova was featured on Korean TV Chosun on 27th Dec 2023 called “Future Revolution, Global Talent War TV CHOSUN Special Documentary”, they were interested in our technology, in why we set up in Singapore and in the internationality of our team and our...